help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akiyama, Y.
Right arrow Articles by Masuda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akiyama, Y.
Right arrow Articles by Masuda, T.
(American Journal of Pathology. 2003;163:1911-1919.)
© 2003 American Society for Investigative Pathology

Cell-Type-Specific Repression of the Maspin Gene Is Disrupted Frequently by Demethylation at the Promoter Region in Gastric Intestinal Metaplasia and Cancer Cells

Yuji Akiyama*{dagger}, Chihaya Maesawa*, Satoshi Ogasawara{dagger}, Masanori Terashima{ddagger} and Tomoyuki Masuda*

From the Departments of Pathology*and Surgery I,{dagger}Iwate Medical University School of Medicine, Morioka; and the Department of Surgery 1,{ddagger}Fukushima Medical University, Fukushima, Japan

Maspin, a serine protease inhibitor, was originally reported as a tumor suppressor gene in breast and prostatic cancers. We examined maspin expression and/or the allele-specific methylation status in four gastric cancer cell lines, as well as normal, metaplastic, and cancerous epithelia obtained from 50 gastric cancer patients. Three gastric cancer cell lines exhibiting maspin overexpression showed hypomethylation at either both alleles or a haploid allele. Only one cell line (GCIY) was maspin-negative but maspin expression was reactivated after treatment with a demethylating agent, 5-aza-2'-deoxycytidine. Dense and diffuse immunoreactivity for maspin was observed in 40 (80%) of 50 gastric cancers and all gastric normal epithelia (GNE) with intestinal metaplasia (IM), but not in GNE without IM. We further analyzed the allele-specific methylation status in 10 of 50 cases subjected to immunohistochemistry by the crypt isolation technique followed by a bisulfite genome sequencing method. The maspin gene promoter region of all GNE without IM was hypermethylated on both alleles whereas those with IM frequently represented the haploid type of hypomethylation status. In six of seven gastric cancers in which crypt isolation was possible, demethylation frequently occurred and extended to both alleles. Maspin mRNA was amplified from GNE with IM and cancerous crypts but not from GNE without IM. These results suggest that demethylation at the maspin gene promoter disrupts the cell-type-specific gene repression in both GNE and gastric cancer.





This article has been cited by other articles:


Home page
Cancer Res.Home page
H. J. Jun, S. Woolfenden, S. Coven, K. Lane, R. Bronson, D. Housman, and A. Charest
Epigenetic Regulation of c-ROS Receptor Tyrosine Kinase Expression in Malignant Gliomas
Cancer Res., March 15, 2009; 69(6): 2180 - 2184.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Yegnasubramanian, M. C. Haffner, Y. Zhang, B. Gurel, T. C. Cornish, Z. Wu, R. A. Irizarry, J. Morgan, J. Hicks, T. L. DeWeese, et al.
DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity
Cancer Res., November 1, 2008; 68(21): 8954 - 8967.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Kanai and S. Hirohashi
Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state
Carcinogenesis, December 1, 2007; 28(12): 2434 - 2442.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M. Woenckhaus, L. Bubendorf, P. Dalquen, J. Foerster, H. Blaszyk, M. Mirlacher, M. Soler, W. Dietmaier, G. Sauter, A. Hartmann, et al.
Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer
J. Clin. Pathol., May 1, 2007; 60(5): 483 - 486.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J J L Wong, N J Hawkins, and R L Ward
Colorectal cancer: a model for epigenetic tumorigenesis
Gut, January 1, 2007; 56(1): 140 - 148.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Khalkhali-Ellis
Maspin: The New Frontier
Clin. Cancer Res., December 15, 2006; 12(24): 7279 - 7283.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C Maesawa, S Ogasawara, A Yashima-Abo, T Kimura, K Kotani, S Masuda, Y Nagata, T Iwaya, K Suzuki, T Oyake, et al.
Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis.
J. Clin. Pathol., March 1, 2006; 59(3): 328 - 330.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
A.P. FEINBERG
A Genetic Approach to Cancer Epigenetics
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 335 - 341.
[Abstract] [PDF]


Home page
Cancer Res.Home page
S. Kim, J. Han, J. Kim, and C. Park
Maspin Expression Is Transactivated by p63 and Is Critical for the Modulation of Lung Cancer Progression
Cancer Res., October 1, 2004; 64(19): 6900 - 6905.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. E. Domann and B. W. Futscher
Flipping the Epigenetic Switch
Am. J. Pathol., June 1, 2004; 164(6): 1883 - 1886.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.